Abdominal aortic aneurysm

From Wikipedia, the free encyclopedia

Abdominal aortic aneurysm Classification and external resources
ICD-10	I71.3, I71.4
ICD-9	441.3, 441.4
OMIM	100070
DiseasesDB	792
MedlinePlus	000162
eMedicine	med/3443  emerg/27 radio/1
MeSH	D017544

Abdominal aortic aneurysm, also written as AAA and often pronounced 'triple-A', is a localized dilatation of the abdominal aorta, that exceeds the normal diameter by more than 50%. The normal diameter of the infrarenal aorta is 2 cm. It is caused by a degenerative process of the aortic wall, however the exact etiology remains unknown. It is most commonly located below the kidneys (infrarenally; 90%), other possible locations are above or at the level of the kidneys (suprarenal and pararenal). The aneurysm can extend to include one or both of the iliac arteries. An aortic aneurysm may also occur in the thorax.

An abdominal aortic aneurysm occurs most commonly in older individuals (between 65 and 75), and more in men and smokers. There is moderate evidence to support screening in individuals with these risk factors. The majority of abdominal aortic aneurysms do not cause symptoms. Symptomatic and large aneurysms (>5 cm in diameter) are considered for repair.

The most important complication of an abdominal aortic aneurysm is rupture, which is most often a fatal event. An abdominal aortic aneurysm weakens the walls of the blood vessel, leaving it vulnerable to bursting open, or rupturing, and spilling large amounts of blood into the abdominal cavity.^[1]

Contents 1 History 2 Epidemiology 3 Etiology 4 Pathophysiology 5 Screening 6 Manifestations and Diagnosis 7 Rupture 8 Treatment 9 References 10 External links

[edit] History

The first historical records about AAA are from Ancient Rome, more precisely from the 2nd century AD, when Greek surgeon Antyllus tried to treat the AAA with proximal and distal ligature, central incision and evacuation of thrombotic material from the aneurysm. However, attempts to treat the AAA surgically were unsuccessful until 1923. In that year, Rudolph Matas (who also proposed the concept of endoaneurysmorrhaphy), performed the first successful aortic ligation on a human.^[2] Other methods that were successful in treating the AAA included wrapping the aorta with polyethene cellophane, which induced fibrosis and restricted the growth of the aneurysm. Albert Einstein was operated on by Rudolf Nissen with use of this technique in 1949, and survived five years after the operation.^[3]

[edit] Epidemiology

AAA is uncommon in individuals of African, Asian, and Hispanic heritage. The frequency varies strongly between males and females. The peak incidence is among males around 70 years of age, the prevalence among males over 60 years totals 2-6%. The frequency is much higher in smokers than in non-smokers (8:1), and the risk decreases slowly after smoking cessation.^[4] Other risk factors include hypertension and male sex.^[5] In the U.S., the incidence of AAA is 2-4% in the adult population. ^[6]. AAA is 4-6 times more common in male siblings of known patients, with a risk of 20-30%.^[7]

Rupture of the AAA occurs in 1-3% of men aged 65 or more, the mortality is 70-95%.^[8]

[edit] Etiology

The exact causes of the degenerative process remain unclear. There are, however, some theories and risk factors defined.

• Genetic influences: The influence of genetic factors is highly probable. The high familial prevalence rate is most notable in male individuals.^[9] There are many theories about the exact genetic disorder that could cause higher incidence of AAA among male members of the affected families. Some presumed that the influence of alpha 1-antitrypsin deficiency could be crucial, some experimental works favored the theory of X-linked mutation, which would explain the lower incidence in heterozygous females. Other theories of genetic etiology were also formulated.^[6]

• Hemodynamic influences: Abdominal aortic aneurysm is a focal degenerative process with predilection for the subrenal aorta. The histological structure and mechanical characteristics of subrenal aorta differ from those of the thoracic aorta. The diameter decreases from the root to the bifurcation, and the wall of the abdominal aorta also contains a lesser proportion of elastin. The mechanical tension in abdominal aortic wall is therefore higher than in the thoracic aortic wall. The elasticity and distensibility also decline with age, which can result in gradual dilatation of the segment. Higher intraluminal pressure in patients with arterial hypertension markedly contributes to the progression of the pathological process.^[5]

• Atherosclerosis: The AAA was long considered to be caused by atherosclerosis, because the walls of the AAA are frequently affected heavily. However, this theory cannot be used to explain the initial defect and the development of occlusion, which is observed in the process.^[6]

• Other causes: Other causes of the development of AAA include: infection, trauma, arteritis, cystic medial necrosis (m. Erdheim) and connective tissue disorders (e.g. Marfan syndrome, Ehlers-Danlos syndrome).^[5]

[edit] Pathophysiology

The most striking histopathological changes of aneurysmatic aorta are seen in tunica media and intima. These include accumulation of lipids in foam cells, extracellular free cholesterol crystals, calcifications, ulcerations and ruptures of the layers and thrombosis. There is an adventitial inflammatory infiltrate.^[5] However, the degradation of tunica media by means of proteolytic process seems to be the basic pathophysiologic mechanism of the AAA development. Some researchers report increased expression and activity of matrix metalloproteinases in individuals with AAA. This leads to elimination of elastine from the media, rendering the aortic wall more susceptible to the influence of the blood pressure. ^[6] Other pathophysiological cause for development of the AAA is inflammation.

[edit] Screening

A clinical practice guideline by the U.S. Preventive Services Task Force "recommends one-time screening for abdominal aortic aneurysm (AAA) by ultrasonography in men age 65 to 75 years who have ever smoked".^[10][11] This is a grade B recommendation^[12]. A re-analysis of the meta-analysis estimated a number needed to screen of approximately 850 patients.^[13]

The largest of the randomized controlled trials on which this guideline was based studied a screening program that consisted of^[14]:

Screening men ages 65-74 years (not restricted to ever smokers). 'Men in whom abdominal aortic aneurysms (> or =3 cm in diameter) were detected were followed-up... Patients with an aortic diameter of 3·0–4·4 cm were rescanned at yearly intervals, whereas those with an aortic diameter of 4·5–5·4 cm were rescanned at 3-monthly intervals ... Surgery was considered on specific criteria (diameter > or =5.5 cm, expansion > or =1 cm per year, symptoms)'.

This trial reported significant short^[14] ( number needed to screen after 4 years of approximately 590 to prevent nonfatal ruptured AAA plus AAA-related deaths^[15]) and long term^[16] ( number needed to screen after 7 years of approximately 280 to prevent nonfatal ruptured AAA plus AAA-related deaths) benefit and cost effectiveness.^[17] Subsequent randomized controlled trials also found benefit:

• number needed to screen after 4 years of 300^[18]
• number needed to screen after and after 7 years of 563 (calculation).^[19]

In the U.S., effective January 1, 2007, provisions of the SAAAVE Act (Screening Abdominal Aortic Aneurysm Very Efficiently) now provide a free, one-time, ultrasound AAA screening benefit for those qualified seniors. Men who have smoked at least 100 cigarettes during their life, and men and women with a family history of AAA qualify for the one-time ultrasound screening. Enrollees must visit their healthcare professional for their Welcome to Medicare physical within six months of enrolment in order to qualify for the free screening. The Welcome to Medicare Physical Exam must be completed within the first six months of Medicare eligibility, but there is no published time limit thereafter for completion of the AAA screening. Providers who perform the physical and order the AAA screening need to document the AAA risk factors.^[20]

[edit] Manifestations and Diagnosis

AAAs are commonly divided according to their size and symptomatology. An aneurysm is usually considered to be present if the measured outer aortic diameter is over 3 cm (normal diameter of aorta is around 2 cm). The natural history is of increasing diameter over time, followed eventually by the development of symptoms (usually rupture). If the outer diameter exceeds 5 cm, the aneurysm is considered to be large. For aneurysms under 5 cm, the risk of rupture is low, so that the risks of surgery usually outweigh the risk of rupture. Aneurysms less than 5cm are therefore usually kept under surveillance until such time as they become large enough to warrant repair, or develop symptoms.^[5][8] The vast majority of aneurysms are asymptomatic. The risk of rupture is high in a symptomatic aneurysm, which is therefore considered an indication for surgery. Possible symptoms include low back pain, flank pain, abdominal pain, groin pain or pulsating abdominal mass.^[21] The complications include rupture, peripheral embolisation, acute aortic occlusion, aortocaval or aortoduodenal fistulae. On physical examination, a palpable abdominal mass can be noted. Bruits can be present in case of renal or visceral arterial stenosis.^[6]

As most of the AAAs are asymptomatic, their presence is usually revealed during an abdominal examination for another reason - the most common being abdominal ultrasonography. A physician may also detect the presence of an AAA by abdominal palpation. Ultrasonography provides the initial assessment of the size and extent of the aneurysm, and is the usual modality for surveillance. Preoperative examinations include CT, MRI and special modes thereof, like CT/MR angiography. Angiography may be useful also, as an additional method of measurement for the planning of endoluminal repair. Note that an aneurysmal aorta may appear normal on angiogram, due to thrombus within the sac.

[edit] Rupture

The clinical manifestation of ruptured AAA can include low back, flank, abdominal or groin pain, but the bleeding usually leads to a hypovolemic shock with hypotension, tachycardia, cyanosis, and altered mental status. The mortality of AAA rupture is up to 90%. 65-75% of patients die before they arrive at hospital and up to 90% die before they reach the operating room.^[22] The bleeding can be retroperitoneal or intraperitoneal, or the rupture can create an aortocaval or aortointestinal fistula.^[5]. Flank ecchymosis (appearance of a bruise) is a sign of retroperitoneal hemorrhage, and is also called the Grey-Turner sign.^[6] Ruptured AAA is a clinical diagnosis: the presence of the triad of abdominal pain, shock and pulsatile abdominal mass makes the diagnosis; no further investigations are required for diagnostic purposes, and imaging should not delay surgery. The operative mortality has slowly decreased over several decades but remains higher than 40%.^[23]

[edit] Treatment

The treatment options for asymptomatic AAA are immediate repair, surveillance with a view to eventual repair, and conservative management. There are currently two modes of repair available for an AAA: open aneurysm repair (OR), and endovascular aneurysm repair (EVAR).

• Conservative treatment is indicated in patients where repair carries a high risk of mortality and also in patients where repair is unlikely to improve life expectancy. The two mainstays of the conservative treatment are smoking cessation and blood pressure control. Recent studies have suggested possible protective effects of therapy with angiotensin converting enzyme inhibitors or statins.^[24][25]
• Surveillance is indicated in small aneurysms, where the risk of repair exceeds the risk of rupture. As an AAA grows in diameter the risk of rupture increases. Surveillance until the aneurysm has reached a diameter of 5cm has not been shown to have a higher risk as compared to early intervention.^[26][27] The threshold for repair varies slightly from individual to individual, depending on the balance of risks and benefits when considering repair versus ongoing surveillance. The size of an individual's native aorta may influence this, along with the presence of comorbitities that increase operative risk or decrease life expectancy.
• Open repair (operation) is indicated in young patients as an elective procedure, or in growing or large, symptomatic or ruptured aneurysms. Open repair has been the mainstay of intervention from the 1950s until recently.
• Endovascular repair first became practical in the 1990s and although it is now an established alternative to open repair, its role is yet to be clearly defined. It is generally indicated in older, high-risk patients or patients unfit for open repair. However, endovascular repair is feasible for only a proportion of AAA's, depending on the morphology of the aneurysm. The main advantage over open repair is that there is less peri-operative mortality, less time in intensive care, less time in hospital overall and earlier return to normal activity. Disadvantages of endovascular repair include a requirement for more frequent ongoing hospital reviews, and a higher chance of further procedures being required. According to the latest studies, the EVAR procedure doesn't offer any benefit for overall survival or health-related quality of life compared to open surgery, although aneurysm-related mortality is lower.^{[28][29][30][31]} In patients unfit for open repair, EVAR plus conservative management was associated with no benefit and more complications and subsequent procedures and higher costs compared to conservative management alone.^[32]

New endovascular devices are being developed that are able to treat more complex and tortuous anatomies.^[33]

[edit] References

[edit] External links

• VIDEO: Factors that Influence Decision Making for Abdominal Aortic Aneurysm Repair Margaret L. Schwarze, MD, speaks at the University of Wisconsin School of Medicine and Public Health, 2007.

v • d • e Cardiovascular disease: vascular disease - Circulatory system pathology (I60-I99, 430-459) Cerebrovascular diseases Intracranial hemorrhage: Extra-axial (Epidural, Subdural, Subarachnoid) - Cerebral/Intra-axial (Intraventricular, Intraparenchymal) Stroke/Brain ischemia: Vertebrobasilar insufficiency (Subclavian steal syndrome) - TIA Carotid artery stenosis - Cerebral aneurysm - Binswanger's disease - Moyamoya disease Anterior spinal artery syndrome Arteries, arterioles and capillaries Arterial occlusive disease: Arteriosclerosis (Atherosclerosis, Intermittent claudication, Atheroma) - Renal artery stenosis - Fibromuscular dysplasia - Degos disease Peripheral vascular disease: Raynaud's phenomenon/Raynaud's disease - Erythromelalgia Aneurysm (Aortic/Abdominal aortic) - Dissection (Aortic, Carotid, Vertebral) - Pseudoaneurysm Arteritis (Aortitis) - Buerger's disease Arteriovenous fistula - Hereditary hemorrhagic telangiectasia Nevus (Spider angioma) Veins Venous thrombosis/Phlebitis/Thrombophlebitis: Deep vein thrombosis - May-Thurner syndrome - Portal vein thrombosis - Budd-Chiari syndrome - Renal vein thrombosis - Paget-Schroetter disease - Post-thrombotic syndrome Varicose veins: Varicocele - Gastric varices - Portacaval anastomosis (Hemorrhoid, Esophageal varices, Caput medusae) Superior vena cava syndrome - Venous ulcer Arteries or veins Vasculitis - Thrombosis - Embolism (Pulmonary embolism, Cholesterol embolism) Lymphatic vessels/nodes Lymphadenitis - Lymphedema - Lymphangitis Blood pressure Hypertension: Hypertensive heart disease - Hypertensive nephropathy - Secondary hypertension (Renovascular hypertension) Hypotension: Orthostatic hypotension See also congenital (Q20-Q28, 745-747)